Tokyo, July 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058647) titled 'FIB-4 is associated with skeletal muscle mass in Japanese patients with type 2 diabetes' on July 30.
Study Type:
Observational
Primary Sponsor:
Institute - Edogawa Hospital
Condition:
Condition - type 2 diabetes mellitus
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluation of the relationship between liver fibrosis and muscle mass in patients with type 2 diabetes
Basic objectives2 - Others
Eligibility:
Age-lower limit - 20
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Adult patients with type 2 diabetes and without liver cirrhosis who underwent body composition analysis using bioelectrical impedance analysis
Key exclusion criteria - Steroid users and patients with liver cirrhosis, renal failure, malnutrition, thrombocytopenia, myelodysplasia syndrome, or idiopathic thrombocytopenic purpura
Target Size - 400
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2024 Year 07 Month 04 Day
Date of IRB - 2024 Year 07 Month 04 Day
Anticipated trial start date - 2024 Year 08 Month 01 Day
Last follow-up date - 2024 Year 08 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067067
Disclaimer: Curated by HT Syndication.
